Cooper Pharma launches construction of $6mn pharmaceutical plant in Rwanda

Leading African pharmaceutical Cooper Pharma broke ground for their $USD 6 million pharmaceutical plant in Rwanda, The factory whose completion is set for 2019, will produce beta-lactam antibiotics and non-beta lactam antibiotics according to the market’s demand. To better understand how this will help Rwanda reduce the import bill on drugs, CNBC Africa’s Michael Mugisha filed this report.

Partner Content

Absa commits to growing African trade with award-winning online platform

Absa launched its online trade finance portal, Trade Management Online, in 2019

Responsible banking in a post-COVID commodity market – Investing responsibly throughout the commodity value chain

While the alcohol sector invariably draws strong feelings from across the philosophical divide during Covid-19, what is indisputable...

A Cyber Pandemic May Be Next: How secure are you in the cloud?

The Coronavirus pandemic has influenced us in a more global way than the Cold War, affecting the environment, industry, finance, healthcare, leisure...

Subscribe to our newsletter

Sign up for free newsletters and get more CNBC AFRICA delivered to your inbox